Global Phage Therapy Supply, Demand and Key Producers, 2026-2032
Description
The global Phage Therapy market size is expected to reach $ 223 million by 2032, rising at a market growth of 18.8% CAGR during the forecast period (2026-2032).
Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are the most common biological entities in nature, and have been shown to effectively fight and destroy multi-drug resistant bacteria. Namely, when all antibiotics fail, phages still succeed in killing the bacteria and may save a life from an infection. phage has many potential applications in human medicine as well as dentistry, veterinary science, and agriculture.
The Bacteriophage market is expected to grow at a significant rate owing to rising prevalence of antibiotic resistant infection, rising research activities for and development of novel therapies, increasing adoption of growth strategies such as acquisitions, and collaborations by market players.
Bacteriophage is a type of virus that attaches itself to a bacterium and infects the host cell, subsequently destroying it. These microorganisms destroy their host cells through a natural process without interacting with human or animal cells. One of the most important sectors where the use of bacteriophages has emerged as very important is the poultry and aquaculture. While the use of bacteriophages in humans is still a rarity in modern medicine, their usage in animal husbandry, rearing poultry and fish is already showing positive results.
The major global companies of Bacteriophage include NPO Microgen, Qingdao Phagepharm Bio-tech, Armata Pharmaceuticals, Inc., Phaxiam Therapeutics, Eliava BioPreparations, Intralytix, MicroMir, Phagelux, and Pharmex Group, LLC, etc. In 2024, the world's top five vendors accounted for approximately 48% of the revenue.
This report studies the global Phage Therapy demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Phage Therapy, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Phage Therapy that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Phage Therapy total market, 2021-2032, (USD Million)
Global Phage Therapy total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Phage Therapy total market, key domestic companies, and share, (USD Million)
Global Phage Therapy revenue by player, revenue and market share 2021-2026, (USD Million)
Global Phage Therapy total market by Type, CAGR, 2021-2032, (USD Million)
Global Phage Therapy total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Phage Therapy market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include NPO Microgen, Qingdao Phagepharm Bio-tech, Armata Pharmaceuticals, Inc., Phaxiam Therapeutics, Eliava BioPreparations, Intralytix, MicroMir, Phagelux, Pharmex Group, LLC, APS Biocontrol Ltd. (APS), etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Phage Therapy market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Phage Therapy Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Phage Therapy Market, Segmentation by Type:
DsDNA Bacteriophage
SsDNA Bacteriophage
SsRNA Bacteriophage
Others
Global Phage Therapy Market, Segmentation by Application:
Human Health
Animal Health
Aquaculture
Agriculture
Food Industry
Others
Companies Profiled:
NPO Microgen
Qingdao Phagepharm Bio-tech
Armata Pharmaceuticals, Inc.
Phaxiam Therapeutics
Eliava BioPreparations
Intralytix
MicroMir
Phagelux
Pharmex Group, LLC
APS Biocontrol Ltd. (APS)
ACD Pharma
Proteon Pharmaceuticals
Micreos
Locus Biosciences, Inc
NexaBiome Limited
PhagePro
BiomX
INtODEWORLD, Inc.
TechnoPhage
PhageLab
SciPhage
Kinzbio
Key Questions Answered
1. How big is the global Phage Therapy market?
2. What is the demand of the global Phage Therapy market?
3. What is the year over year growth of the global Phage Therapy market?
4. What is the total value of the global Phage Therapy market?
5. Who are the Major Players in the global Phage Therapy market?
6. What are the growth factors driving the market demand?
Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are the most common biological entities in nature, and have been shown to effectively fight and destroy multi-drug resistant bacteria. Namely, when all antibiotics fail, phages still succeed in killing the bacteria and may save a life from an infection. phage has many potential applications in human medicine as well as dentistry, veterinary science, and agriculture.
The Bacteriophage market is expected to grow at a significant rate owing to rising prevalence of antibiotic resistant infection, rising research activities for and development of novel therapies, increasing adoption of growth strategies such as acquisitions, and collaborations by market players.
Bacteriophage is a type of virus that attaches itself to a bacterium and infects the host cell, subsequently destroying it. These microorganisms destroy their host cells through a natural process without interacting with human or animal cells. One of the most important sectors where the use of bacteriophages has emerged as very important is the poultry and aquaculture. While the use of bacteriophages in humans is still a rarity in modern medicine, their usage in animal husbandry, rearing poultry and fish is already showing positive results.
The major global companies of Bacteriophage include NPO Microgen, Qingdao Phagepharm Bio-tech, Armata Pharmaceuticals, Inc., Phaxiam Therapeutics, Eliava BioPreparations, Intralytix, MicroMir, Phagelux, and Pharmex Group, LLC, etc. In 2024, the world's top five vendors accounted for approximately 48% of the revenue.
This report studies the global Phage Therapy demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Phage Therapy, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Phage Therapy that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Phage Therapy total market, 2021-2032, (USD Million)
Global Phage Therapy total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Phage Therapy total market, key domestic companies, and share, (USD Million)
Global Phage Therapy revenue by player, revenue and market share 2021-2026, (USD Million)
Global Phage Therapy total market by Type, CAGR, 2021-2032, (USD Million)
Global Phage Therapy total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Phage Therapy market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include NPO Microgen, Qingdao Phagepharm Bio-tech, Armata Pharmaceuticals, Inc., Phaxiam Therapeutics, Eliava BioPreparations, Intralytix, MicroMir, Phagelux, Pharmex Group, LLC, APS Biocontrol Ltd. (APS), etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Phage Therapy market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Phage Therapy Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Phage Therapy Market, Segmentation by Type:
DsDNA Bacteriophage
SsDNA Bacteriophage
SsRNA Bacteriophage
Others
Global Phage Therapy Market, Segmentation by Application:
Human Health
Animal Health
Aquaculture
Agriculture
Food Industry
Others
Companies Profiled:
NPO Microgen
Qingdao Phagepharm Bio-tech
Armata Pharmaceuticals, Inc.
Phaxiam Therapeutics
Eliava BioPreparations
Intralytix
MicroMir
Phagelux
Pharmex Group, LLC
APS Biocontrol Ltd. (APS)
ACD Pharma
Proteon Pharmaceuticals
Micreos
Locus Biosciences, Inc
NexaBiome Limited
PhagePro
BiomX
INtODEWORLD, Inc.
TechnoPhage
PhageLab
SciPhage
Kinzbio
Key Questions Answered
1. How big is the global Phage Therapy market?
2. What is the demand of the global Phage Therapy market?
3. What is the year over year growth of the global Phage Therapy market?
4. What is the total value of the global Phage Therapy market?
5. Who are the Major Players in the global Phage Therapy market?
6. What are the growth factors driving the market demand?
Table of Contents
157 Pages
- 1 Supply Summary
- 2 Demand Summary
- 3 World Phage Therapy Companies Competitive Analysis
- 4 United States VS China VS Rest of World (by Headquarter Location)
- 5 Market Analysis by Type
- 6 Market Analysis by Application
- 7 Company Profiles
- 8 Industry Chain Analysis
- 9 Research Findings and Conclusion
- 10 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
